Advancements in molecular cloning research due to the emergence of new technologies and the growing commercial demand for molecular cloned products and recombinant proteins are some the key factors driving the growth of this market. On the other hand, increasing market consolidation creating strong entry barriers and high cost of competent cells kits are restraining the growth of this market.
Competent Cells Market by type 2017-2022 by new Service spreads across 159 pages profiling 13 companies and supported with 101 tables and 39 figures available at ReportsnReports.com
Browse report here@ www.reportsnreports.com/reports/11…i-st-to-2022.html
The global Competent Cells Market is projected to reach USD 2.22 billion by 2022 from USD 1.37 billion in 2017, at a CAGR of 10.2%.
The electro competent cells segment is expected to register the highest CAGR during the forecast period
The competent cells market is classified on the basis of type into chemically competent cells and electro competent cells.
Electro competent cells are expected to grow at the highest CAGR during the forecast period. Electro competent cells offer high transformation efficiencies, making them suitable for many molecular biology applications such as the generation of cDNA libraries or constructing gene banks.
Increasing intensity of research and technological advancements drives growth of the other applications segment
Based on application, the global competent cells market is broadly segmented into cloning, protein expression, and other applications. The other applications segment is expected to register the highest CAGR during the forecast period.
Pharmaceutical & biotechnology companies segment is expected to witness the highest growth
The competent cells market is classified on the basis of end users into academic research institutes, contract research organizations (CROs), and pharmaceutical & biotechnology companies. Pharmaceutical & biotechnology companies are expected to grow at the highest CAGR during the forecast period.
Fundamental of Table of Content
Competent Cells Market, By Type
- Chemically Competent Cells
- Electrocompetent Cells
Competent Cells Market, By Application
- Subcloning & Routine Cloning
- Phage Display Library Construction
- Toxic/Unstable Dna Cloning
- High-Throughput Cloning
- Protein Expression
- Other Applications
- Large Plasmid Transformation
- Single-Stranded Dna Production
- Lentiviral Vector Production
11 Company Profiles
(Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development’s, Business Strategy)*
11.1 Thermo Fisher Scientific, Inc.
11.2 Merck KGaA
11.3 Promega Corporation
11.4 Takara Bio, Inc.
11.5 New England Biolabs, Inc.
11.6 Bio-Rad Laboratories, Inc.
11.7 Transgen Biotech, Inc.
11.8 Agilent Technologies, Inc.
11.9 Illumina, Inc.
11.10 Zymo Research
11.11 Qiagen N.V.
11.12 Genscript Biotech Corporation
11.13 Origene Technologies, Inc.
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offerings, Recent Developments, and Business Strategies Might Not Be Captured in Case of Unlisted Companies.